NCT07423962

Brief Summary

This study is a randomized controlled experimental trial designed to evaluate the effects of a researcher-developed sleep cap on the sleep and physiological variables of infants hospitalized in the Neonatal Intensive Care Unit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
4.7 years until next milestone

First Submitted

Initial submission to the registry

December 9, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 20, 2026

Completed
Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

December 9, 2025

Last Update Submit

February 21, 2026

Conditions

Keywords

Physiological variablesNewbornsleepNeonatal Intensive Care Unitneonatal careNursing care

Outcome Measures

Primary Outcomes (6)

  • Infant's Night Sleep Duration

    The duration (in minutes) of continuous sleep between 19:00 and 07:00 was determined by watching video recordings from three days of monitoring. For each monitoring day, the average sleep duration (in minutes) over a 12-hour period (19:00-07:00) was determined.

    For three days, between 19:00 and 07:00.

  • Number of Nighttime Awakenings of the Infants

    During three monitoring days, the number of times the ınfant woke up between 19:00 and 07:00 was determined by watching video recordings. For each monitoring day, the number of awakenings in a 12-hour period (19:00-07:00) was determined.

    For three days, between 19:00 and 07:00

  • Heart Rate

    The infants' heart rate (beats per minute) was monitored using bedside monitors. For each monitoring day, a 12-hour average heart rate (beats per minute) was recorded (between 19:00 and 07:00).

    For three days, between 19:00 and 07:00

  • Respiratory Rate

    The respiratory rate (respiratory rate/minute) of the infants was monitored using bedside monitors. For each monitoring day, the average respiratory rate (respiratory rate/minute) was taken over 12 hours (between 19:00 and 07:00).

    For three days, between 19:00 and 07:00

  • Oxygen saturation

    Oxygen saturation (%) of infants was monitored with bedside monitors. For each monitoring day, the 12-hour (between 19:00 and 07:00) average oxygen saturation was taken (%).

    For three days, between 19:00 and 07:00

  • Body Temperature

    The infant's body temperature (°C) was measured with a thermometer suitable for infants. For each monitoring day, the 12-hour average body temperature (between 19:00 and 07:00) was taken (°C).

    For three days, between 19:00 and 07:00

Study Arms (2)

Sleep caps group:Newborns in the experimental group were fitted sleep caps

EXPERIMENTAL

Demographic characteristics, clinical findings, and physiological variables (heart rate, respiratory rate, saturation value, and body temperature) of the infants in the study group were recorded. The newborns in the study group were fitted with sleeping hats for three days between 7:00 PM and 7:00 AM, and the hats were removed when they woke. 12 hours of uninterrupted video recording was conducted during this time. The newborns' sleeping and waking times, as well as the reasons for waking, were recorded. The video recordings were viewed and evaluated by both the researcher and an independent expert (pediatrician) from the study.

Other: Wearing a Sleep Cap

Control group

NO INTERVENTION

Demographic characteristics, clinical findings, and physiological variables (heart rate, respiratory rate, saturation value, and body temperature) of the infants in the control group were recorded. Newborns in the control group underwent clinical routines for three days, and uninterrupted video recordings were made between 7:00 PM and 7:00 AM. The newborns' sleeping and waking times, as well as the reasons for waking, were recorded. The video recordings were viewed and evaluated by both the researcher and an independent expert (pediatrician) from the study.

Interventions

Demographic characteristics, clinical findings, and physiological variables (heart rate, respiratory rate, saturation value, and body temperature) of the infants in the study group were recorded. The newborns in the study group were fitted with sleeping caps for three days between 7:00 PM and 7:00 AM, and the caps were removed when they woke. 12 hours of uninterrupted video recording was conducted during this time. The newborns' sleeping and waking times, as well as the reasons for waking, were recorded. The video recordings were viewed and evaluated by both the researcher and an independent expert (pediatrician) from the study.

Sleep caps group:Newborns in the experimental group were fitted sleep caps

Eligibility Criteria

Age32 Weeks - 42 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Newborns who are over 32 weeks gestation and are hospitalized in the NICU
  • Newborns stable in room air conditions

You may not qualify if:

  • Premature infants birth under 32 weeks
  • Newborns receiving phototherapy treatment
  • Newborns receiving respiratory support
  • Newborns with congenital anomalies
  • Newborns receiving medication that affects sleep (such as caffeine)
  • Newborns with sepsis
  • Newborns with congenital diseases
  • Newborns with diseases affecting the central nervous system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aydın Adnan Menderes University, Faculty of Nursing, Department of Child Health and Disease Nursing

Aydin, Efeler, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Evaluated by a pediatrician independent of the study
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: stratified randomization newborns between 32 and 37 weeks of gestation were matched stratified with newborns between 38 and 42 weeks of gestation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 9, 2025

First Posted

February 20, 2026

Study Start

September 1, 2020

Primary Completion

March 31, 2021

Study Completion

March 31, 2021

Last Updated

February 24, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Datasets that are continuously and/or analyzed during the current study can be obtained from the author upon request.

Shared Documents
CSR
Time Frame
6 months after publication
Access Criteria
It must be relevant to the subject of the study and approval from all co-authors must be obtained within 1 month of receiving the request.

Locations